MSC-derived IL-6 induces endothelin-1 (ET-1) secretion from cancer cells, which activates the AKT and ERK pathways in endothelial cells to promote endothelial cell recruitment and tumor neovascularization in gastrointestinal cancer cells. Here, EDN1 is linked to neoplasm.